Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM225CWN
HER2amp
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7534.091
uM
10.57980
18.55160
-0.9993 -1.0000 1.9562 0.5265
0.9981
0.9898
SUM225CWN
HER2amp
Basal A
Ispinesib
KSP
Kinesin
7533.067
uM
0.11585
1.15460
-0.9946 -1.0000 0.4778 0.5454
0.8973
1.0554
SUM225CWN
HER2amp
Basal A
Ispinesib
KSP
Kinesin
7534.067
uM
0.11494
0.99902
-0.9982 -1.0000 0.5081 0.5924
0.9238
1.1276
SUM225CWN
HER2amp
Basal A
Ixabepilone
TUBB
TUBB
7534.095
uM
0.00261
0.12623
-0.9999 -1.0000 0.2832 0.9398
0.7408
0.8052
SUM225CWN
HER2amp
Basal A
Ixabepilone
TUBB
TUBB
7533.095
uM
0.03209
0.58907
-0.9854 -1.0000 0.3775 0.6854
0.8929
0.9850
SUM225CWN
HER2amp
Basal A
JNK-IN-5A
JNK
JNK
12098.144
uM
inf
inf
0.8183 0.8183 0.0000 0.1139
0.5003
1.1959
SUM225CWN
HER2amp
Basal A
JNK-IN-5A
JNK
JNK
10579.144
uM
2.03580
1.68810
0.3098 0.3040 5.0000 0.2207
0.9721
0.9576
SUM225CWN
HER2amp
Basal A
L-779450
BRAF
MAPK
12098.161
uM
7.89360
24.63020
-0.3465 -1.0000 0.9655 0.1605
0.9832
1.4196
SUM225CWN
HER2amp
Basal A
L-779450
BRAF
MAPK
10579.137
uM
6.83690
7.39060
-0.2373 -0.2380 4.9998 0.1278
0.9841
0.9202
SUM225CWN
HER2amp
Basal A
Lapatinib
EGFR/HER2
ErbB
7533.098
uM
0.68808
0.72289
-0.1508 -0.1399 4.9987 0.2359
0.9929
0.8545
SUM225CWN
HER2amp
Basal A
Lapatinib
EGFR/HER2
ErbB
7534.098
uM
0.62293
0.82639
-0.3240 -0.3217 1.7576 0.2906
0.9956
0.9286
SUM225CWN
HER2amp
Basal A
LBH589
HDAC
HDAC
12098.154
uM
0.11096
0.24122
-0.9287 -0.9769 1.3948 0.7432
0.9935
0.9724
SUM225CWN
HER2amp
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12098.154
uM
1.18010
2.08150
-0.7514 -0.8076 1.6941 0.4116
0.9814
0.9724
SUM225CWN
HER2amp
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10579.142
uM
0.85957
2.07090
-0.9176 -0.9154 1.1835 0.5543
0.9976
1.0435
SUM225CWN
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7534.084
uM
inf
inf
0.9557 0.9557 0.0000 0.0114
0.0130
0.8905
SUM225CWN
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7533.084
uM
inf
inf
0.9294 0.9294 0.0000 -0.0224
0.2330
1.0396
SUM225CWN
HER2amp
Basal A
MG-132
Proteasome
Proteasome
10579.145
uM
0.10501
0.22014
-0.5744 -0.5606 1.0159 0.6768
0.9729
1.0664
SUM225CWN
HER2amp
Basal A
MG-132
Proteasome
Proteasome
10579.145
uM
0.10501
0.22014
-0.5744 -0.5606 1.0159 0.6768
0.9729
1.0664
SUM225CWN
HER2amp
Basal A
MG-132
Proteasome
Proteasome
12098.145
uM
0.06807
0.12086
-0.6944 -0.6272 1.4159 0.7837
0.9869
0.9769
SUM225CWN
HER2amp
Basal A
MG-132
Proteasome
Proteasome
12098.145
uM
0.06807
0.12086
-0.6944 -0.6272 1.4159 0.7837
0.9869
0.9769
SUM225CWN
HER2amp
Basal A
Pevonedistat
NAE1
NAE1
10579.135
uM
4.48940
10.87060
-0.4907 -0.7214 1.0099 0.3005
0.930
0.7853
SUM225CWN
HER2amp
Basal A
Pevonedistat
NAE1
NAE1
12098.135
uM
4.4780
9.06550
-0.2888 -0.4856 0.9622 0.2497
0.9858
1.2823
SUM225CWN
HER2amp
Basal A
Nilotinib
ABL
nRTK
10579.145
uM
inf
inf
0.7382 0.7382 0.0000 0.1219
0.2766
1.0664
SUM225CWN
HER2amp
Basal A
Nilotinib
ABL
nRTK
12098.145
uM
inf
inf
0.9374 0.9374 0.0000 0.0259
0.3617
0.9769
SUM225CWN
HER2amp
Basal A
NSC 663284
CDC25
CDC
12098.159
uM
2.24320
4.11360
-0.9847 -1.0000 1.8117 0.5831
0.9949
1.0261